CIK 0001991792
- Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371611499
- Phone
- +1 949-409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- 4 Planned sale Director sold 1,000 shares at $28.61 ($28,610)
- 4 Planned sale Director sold 1,000 shares at $29.66 ($29,660)
- 4 Open-market sale Director sold 700,000 shares at $28.00 ($19,600,000)
- 4 Planned sale Director sold 1,000 shares at $28.84 ($28,840)
- 4 Planned sale Director sold 1,000 shares at an average $34.54 ($34,542)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 650,455 shares at $35.36 ($23,000,089)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy 10% owner bought 400,000 shares at $19.00 ($7,600,000)
Page 4 of 5 · 96 filings